Table 3. Molecular and serological screening results of pathogens in owned, free-roaming domestic cats. Pathogen occurrence by study area and sex.
| Serology | Molecular analyses | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELISA | IFA/SNT | Piroplasmida | Bartonella spp. | Ehrlichia/Anaplasma | Rickettsia spp. | ||||||||||||||||||
| FeLV | FIV | CDV | |||||||||||||||||||||
| n/total | % | 95%CI | n | % | 95%CI | n/total | % | 95%CI | n/total | % | 95%CI | n/total | % | 95%CI | n/total | % | 95%CI | n/total | % | 95%CI | |||
| Area | |||||||||||||||||||||||
| Valdivia | 1/37 | 2.7 | 2.7–8.1 | 0/37 | 0.0 | 0.0 | 1/37 | 2.7 | 1.6–2.7 | 1/15 | 6.6 | 7.6–20.9 | 3/15 | 20.0 | 2.9–42.9 | 2/15 | 13.3 | 6.1–32.82 | 0/15 | 0.0 | 0.0 | 0.0 | |
| Chiloe | 9/75 | 12.0 | 3.7–32.7 | 2/75 | 2.6 | 1.0–6.3 | 0/75 | 0.0 | 0.0 | 0/15 | 0.0 | 0.0 | 0/15 | 0.0 | 0.0 | 0/15 | 0.0 | 0.0 | 0/15 | 0.0 | 0.0 | 0.0 | |
| Total | 10/112 | 8.9 | 3.5–14.2 | 2/112 | 1.7 | 0.7–4.2 | 1/112 | 0.8 | 0.08–2.6 | 1/30 | 3.3 | 3.4–10.15 | 3/30 | 10.0 | 1.3–21.39 | 2/30 | 6.6 | 2.8–16.14 | 0/30 | 0.0 | 0.0 | 0.0 | |
| Sex | |||||||||||||||||||||||
| Male | 4/47 | 8.5 | 0.2–16.7 | 0/47 | 0.0 | 0.0 | 1/47 | 2.1 | 2.1–6.4 | 0/14 | 0.0 | 0.0 | 1/14 | 7.1 | 8.2–22.5 | 2/14 | 14.2 | 6.6–35.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Female | 6/65 | 9.23 | 2.0–16.4 | 2/65 | 3.0 | 1.2–7.3 | 0/65 | 0.0 | 0.0 | 1/16 | 6.2 | 7.7–19.5 | 2/16 | 12.5 | 5.7–30.7 | 0/16 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
IFA, immunofluorescence assay; SNT, serum neutralization test; C.I.,Confidence intervals (lower-upper); FIV, feline immunodeficiency virus; FeLV, feline leukemia virus; CDV, canine distemper virus.